Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

NCT00993447 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Dengue
Dengue Hemorrhagic Fever
Dengue Virus
Dengue Fever

Interventions

BIOLOGICAL: CYD Dengue Vaccine
BIOLOGICAL: Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis

Sponsor

Sanofi Pasteur, a Sanofi Company